How food and beverage companies can stay ahead of the changes caused by GLP-1 drugs
The following is a guest post from Bryan Radtke and Jeremy Bartlow, growth strategy experts at PA Consulting. GLP-1 drugs — including Wegovy, Mounjaro, Ozempic and others — are revolutionizing the fight against Type 2 diabetes and obesity. These …